Skip to main content

Advertisement

SpringerLink
Log in

Role of indocyanine green combined with radiotracer-Technetium 99 m in neck surgery for primary and recurrent head and neck cancer: preliminary results of a tertiary cancer center

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Purpose

Neck dissection (ND), whether therapeutic or elective, is an essential component of the treatment of head and neck squamous cell carcinoma (HNSCC). Due to altered anatomy and fibrosis caused by initial treatments, surgeons face challenges during salvage ND. A combination of Technetium-99 m and indocyanine green (ICG) previously used in the sentinel lymph node (SLN) biopsy for oral cavity cancers, may be useful in different types of neck surgeries. We aimed to show the additional advantage of this combination in detecting HNSCC and thyroid cancer recurrences, as well as individual lymphatic drainage in elective ND.

Methods

We retrospectively reviewed medical records of patients, underwent neck surgery guided with ICG and Tc-99 m, in Hacettepe University Hospital between June 2018 and December 2020. In a total of 28 patients, intraoperative gamma probes were paired with near infrared (NIR) cameras. Patients are divided into two groups: neck surgery with recurrent occult lesion localization (NS- ROLL) (n: 14) and ND with SLN screening (ND-SLNS) (n: 14).

Results

Among all 14 patients in NS-ROLL group, recurrent diseases, hidden behind tissues were 100% successfully localized. In ND-SLNS group, 238 lymph nodes were harvested, metastasis rate was 31.3% (10/32) in sentinel nodes. SLNS revealed 100% accuracy in detecting metastasis in clinically N0 neck (10/238). Contralateral lymphatic drainage was observed in three patients (lateral-sided oral cavity SCC). In two patients (floor of mouth), three sentinel nodes were detected by NIR only.

Conclusion

The use of ICG-radiotracer provides additional value in disease removal for both primary and recurrent tumors of the head and neck.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Leemans CR, Tiwari R, Nauta JJ, van dW I, Snow GB (1993) Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 71:452–456

    Article  CAS  Google Scholar 

  2. Layland MK, Sessions DG, Lenox J (2005) The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+ Laryngoscope 115:629–639.

  3. Ilgan S, Ozturk E, Yildiz R, Emer O, Ayan A, Gorgulu S et al (2010) Combination of preoperative ultrasonographic mapping and radioguided occult lesion localization in patients with locally recurrent/persistent papillary thyroid carcinoma: a practical method for central compartment reoperations. Clin Nucl Med 35(11):847–852

    Article  Google Scholar 

  4. van den Berg NS, Brouwer OR, Klop WMC, Karakullukcu B, Zuur CL, Tan IB et al (2012) Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-Tc 99m- nanocolloid. Eur J Nucl Med Mol Imaging 39:1128–1136

    Article  CAS  Google Scholar 

  5. Brouwer OR, Buckle T, Vermeeren L, Klop WM, Balm AJ, van der Poel HG et al (2012) Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med 53(7):1034–1040

    Article  CAS  Google Scholar 

  6. Paredes P, Vidal-Sicart S, Campos F, Tapias A, Sanchez N, Martinez S et al (2017) Role of ICG-(99m)Tc-nanocolloid for sentinel lymph node detection in cervical cancer: a pilot study. Eur J Nucl Med Mol Imaging 44(11):1853–1861

    Article  CAS  Google Scholar 

  7. Giammarile F, Schilling C, Gnanasegaran G, Bal C, Oyen WJG, Rubello D et al (2019) The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma. Eur J Nucl Med Mol Imaging 46(3):623–637

    Article  Google Scholar 

  8. Chakera AH, Hesse B, Burak Z, Ballinger JR, Britten A, Caraco C et al (2009) EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging 36(10):1713–1742

    Article  CAS  Google Scholar 

  9. Tuncel M, Suslu N (2019) Radioguided occult lesion localization in patients with recurrent thyroid cancer. Eur Arch Otorhinolaryngol 276(6):1757–1766

    Article  Google Scholar 

  10. Jung YS, Kim SK, Park I, Ryu J, Kim SW, Lee CY et al (2014) Surgical targeting of recurrent thyroid cancer using a novel mixture of 99m-technetium macroaggregated albumin and indocyanine green. Surg Innov 21(6):622–629

    Article  Google Scholar 

  11. van den Brekel MW, van der Waal I, Meijer CJ, Freeman JL, Castelijns JA, Snow GB (1996) The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 106:987–991

    Article  Google Scholar 

  12. Civantos FJ, Zitsch RP, Schuller DE et al (2010) Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1–T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. J Clin Oncol 28(8):1395–1400

    Article  Google Scholar 

  13. Flach GB, Bloemena E, Klop WMC, van ES RJJ, Schepman KP, Hoekstra OS, et al. Sentinel lymph node biopsy in clinically N0 T1–T2 staged oral cancer: The Dutch multicenter trial. Oral Oncology 2014; 50(2014):1020–1024

  14. Ross GL, Soutar DS, MacDonald GD, Shoaib T, Ivan Camilleri I, Roberton AG et al (2004) Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 11(7):690–696

    Article  Google Scholar 

  15. Den Toom IJ, Heuveling DA, Flach GB, van Weert S, Karagozoglu KH, van Schie A et al (2015) Sentinel node biopsy for early-stage oral cavity cancer: The VU University Medical Center experience. Head Neck 37:573–578

    Article  Google Scholar 

  16. Chao C, Wong SL, Edwards MJ, Ross MI, Reintgen DS, Noyes RD et al (2003) Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol 10:21–26

    Article  Google Scholar 

  17. Motomura K, Inaji H, Komoike Y, Kasugai T, Noguchi S, Koyama H (1999) Sentinel node biopsy guided by indocyanine green dye in breast cancer patients. Jpn J Clin Oncol 29:604–607

    Article  CAS  Google Scholar 

  18. KleinJan GH, Bunschoten A, van den Berg NS, Olmos RA, Klop WM, Horenblas S et al (2016) Fluorescence guided surgery and tracer-dose, fact or fiction? Eur J Nucl Med Mol Imaging 43:1857–1867

    Article  CAS  Google Scholar 

  19. Bredell MG (2010) Sentinel lymph node mapping by indocyanin green fluorescence imaging in oropharyngeal cancer—preliminary experience. Head Neck Oncol 2:31 ([PubMed: 21034503])

    Article  Google Scholar 

  20. van der Poel HG, Buckle T, Brouwer OR, Valdés Olmos RA, van Leeuwen FW (2011) Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol 60(4):826–833

    Article  Google Scholar 

  21. Capote-Moreno A, Naval L, Muñoz-Guerra MF, Sastre J, Rodríguez- Campo FJ (2010) Prognostic factors influencing contralateral neck lymph node metastases in oral and oropharyngeal carcinoma. J Oral Maxillofac Surg 68:268–275

    Article  Google Scholar 

  22. Koo BS, Lim YC, Lee JS, Choi EC (2006) Management of contralateral N0 neck in oral cavity squamous cell carcinoma. Head Neck 28:896–901

    Article  Google Scholar 

  23. Kurita H, Koike T, Jun-nosuke N, Sakai H, Nakatsuka A, Uehara S et al (2004) Clinical predictors for contralateral neck lymph node metastasis from unilateral squamous cell carcinoma in the oral cavity. Oral Oncol 40:898–903

    Article  Google Scholar 

  24. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J (1999) Second neoplasm in patients with head and neck cancer. Head Neck 21:204–210

    Article  CAS  Google Scholar 

  25. Vaamonde P, Martin C, del Rio M, LaBella T (2003) Second primary malignancies in patients with cancer of the head and neck. Otolaryngol Head Neck Surg 129:65–70

    Article  Google Scholar 

  26. Jones AS, Morar P, Phillips DE, Field JK, Husband D, Helliwell TR (1995) Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 75:1343–1353

    Article  CAS  Google Scholar 

  27. Flach GB, Broglie MA, van Schie A, Bloemena E, Leemans CR, de Bree R et al (2012) Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma in the previously treated neck. Oral Oncol 48:85–89

    Article  Google Scholar 

  28. Den Toom IJ, Boeve K, van Weert S, Bloemena E, Brouwers AH, Hoekstra OS et al (2019) High rate of unexpected lymphatic drainage patterns and a high accuracy of the sentinel lymph node biopsy in oral cancer after previous neck treatment. Oral Oncol 94:68–72

    Article  Google Scholar 

  29. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, Tjulandin S, Shin DM, Cullen K, Ervin TJ, Murphy BA, Raez LE, Cohen RB et al (2007) Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705–1715

    Article  CAS  Google Scholar 

  30. Brockstein B, Haraf DJ, Rademaker AW, Kies MS, Stenson KM, Rosen F, Mittal BB, Pelzer H, Fung BB, Witt ME, Wenig B, Portugal L, Weichselbaum RW, Vokes EE (2004) Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol 15:1179–1186

    Article  CAS  Google Scholar 

  31. Bourhis J, Le Maître A, Baujat B, Audry H, Pignon JP; Meta-Analysis of Chemotherapy in Head, Neck Cancer Collaborative Group; Meta-Analysis of Radiotherapy in Carcinoma of Head, Neck Collaborative Group; Meta- Analysis of Chemotherapy in Nasopharynx Carcinoma Collaborative Group. Individual patients’ data meta- analyses in head and neck cancer. Curr Opin Oncol. 2007; 19:188–94.

  32. Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP, Morris LG (2014) Decision making in the management of recurrent head and neck cancer. Head Neck 36:144–151

    Article  Google Scholar 

  33. Goodwin WJ Jr (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(2 Suppl 93):1–18

    Article  Google Scholar 

  34. van der Putten L, van den Broek GB, de Bree R, van den Brekel MWM, Balm AJM, Hoebers FJP et al (2009) Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head Neck 31:593–603

    Article  Google Scholar 

  35. Robbins KT, Doweck I, Samant S, Vieira F (2005) Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation. Arch Otolaryngol Head Neck Surg 131:965–969

    Article  Google Scholar 

  36. American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, Doherty GM, Haugen BR, Kloos RT et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19(11):1167–1214

  37. Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97(5):418–428

    Article  CAS  Google Scholar 

  38. Pai SI, Tufano RP (2010) Reoperation for recurrent/persistent well-differentiated thyroid cancer. Otolaryngol Clin North Am 43(2):353–363

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology-Head and Neck Surgery, Faculty of Medicine, Hacettepe University, Sıhhiye, 06100, Ankara, Turkey

    Nilda Sütay Süslü & Oğuzhan Katar

  2. Department of Nuclear Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey

    Murat Tuncel

Authors
  1. Nilda Sütay Süslü
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oğuzhan Katar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murat Tuncel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nilda Sütay Süslü.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Süslü, N.S., Katar, O. & Tuncel, M. Role of indocyanine green combined with radiotracer-Technetium 99 m in neck surgery for primary and recurrent head and neck cancer: preliminary results of a tertiary cancer center. Eur Arch Otorhinolaryngol 279, 1549–1560 (2022). https://doi.org/10.1007/s00405-021-06931-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-021-06931-1

Keywords

Search

Navigation